Symbotic (US:SYM)2025-11-24 21:03Financial Performance - Symbotic reported Q4 fiscal year 2025 revenue of $618 million, a 9.4% increase from $565 million in Q4 fiscal year 2024[2] - The company experienced a net loss of $19 million in Q4 fiscal year 2025, compared to a net income of $16 million in the same quarter last year[2] - Adjusted EBITDA for Q4 fiscal year 2025 was $49 million, up from $42 million in Q4 fiscal year 2024, reflecting a 16.7% increase[2] - For the full fiscal year 2025, revenue reached $2,247 million, representing a 26% year-over-year growth[3] - The net loss for the full fiscal year 2025 was $91 million, with adjusted EBITDA totaling $147 million[3] Cash and Liquidity - Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of Q4 fiscal year 2025[2] - Free cash flow for the three months ended September 27, 2025, was $494,434,000, compared to a negative free cash flow of $153,210,000 in the same period of 2024[24] - The company reported a net cash provided by operating activities of $530,680,000 for the three months ended September 27, 2025[24] - Cash and cash equivalents rose to $1,244,993 thousand, compared to $727,310 thousand in the previous year, marking an increase of 71%[28] - The company reported a net increase in cash, cash equivalents, and restricted cash of $466,553 thousand for the three months ended September 27, 2025[31] Operational Metrics - Total revenue for the three months ended September 27, 2025, was $618,457,000, an increase of 4.7% compared to $592,121,000 for the same period in 2024[20] - Gross profit for the three months ended September 27, 2025, was $127,121,000, representing a gross profit margin of 20.6%, up from 18.2% in the previous year[23] - Operating income for the three months ended September 27, 2025, was a loss of $21,762,000, compared to a loss of $36,556,000 in the same period of 2024[20] - Adjusted EBITDA for the three months ended September 27, 2025, was $49,442,000, an increase from $45,394,000 in the previous year[23] - Total operating expenses for the three months ended September 27, 2025, were $148,883,000, compared to $144,178,000 in the same period of 2024[20] Customer and Market Expansion - The company added Medline as its first customer in the healthcare vertical, indicating expansion into new markets[3] - Symbotic's management expressed optimism about the transition to next-generation storage structures, aligning with customer expectations[3] - The company is focused on enhancing operational systems and margin expansion as part of its growth strategy[3] Balance Sheet and Equity - Total assets increased to $2,401,197 thousand in September 2025, up from $1,578,552 thousand in September 2024, representing a growth of 52%[28] - Total current liabilities increased to $1,729,423 thousand, up from $1,017,146 thousand, reflecting a rise of 70%[28] - Total stockholders' equity rose to $221,318 thousand, compared to $197,233 thousand in the previous year, an increase of 12%[28] - The number of Class A Common Shares outstanding increased to 112,635,932 as of September 27, 2025, from 104,689,377 a year earlier[26] Research and Development - Research and development expenses for the three months ended September 27, 2025, were $58,732,000, an increase of 12.4% from $52,147,000 in the same period last year[24] Deferred Revenue and Stock-Based Compensation - Deferred revenue increased significantly to $1,242,312 thousand, up from $676,314 thousand, indicating a growth of 83%[28] - The company incurred stock-based compensation expenses of $64,368 thousand for the three months ended September 27, 2025, compared to $49,440 thousand in the previous quarter[30]